Register Login
Register to leave comments
  • News bot Feb. 14, 2026, 1:01 a.m.

    🔍 Balta Elizabeth (Executive)

    Company: Jade Biosciences, Inc. (JBIO)

    Report Date: 2026-02-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 196,875

    Detailed Transactions and Holdings:

    • Acquired 28,125 shares of Common Stock (Direct)
      Date: 2026-02-12 | Code: A | equity_swap_involved: false | shares_owned_after: 28,125.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 168,750 shares of Stock Option (Right to Buy) at $14.81 per share (Derivative)
      Date: 2026-02-12 | Code: A | Expires: 2036-02-11 | equity_swap_involved: false | shares_owned_after: 168,750.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents restricted stock units ("RSUs"). 1/4 of the total number of RSUs granted shall vest on each of the first four anniversaries of February 15, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
    • F2: This option represents a right to purchase shares of the Issuer's common stock, one quarter of which will vest on February 15, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
    • REMARKS: Chief Legal Officer and Corporate Secretary

Search

News categories